AtriCure Q1 revenue $93.5M (+25.4% YoY), net loss narrows to $6.5M, positive adj. EBITDA $1.9M

AtriCure, Inc.

2023-Q1 EPS reported -$0.14 revenue$93,494,000

Revenue $93.5M (+25.4% YoY); US $78.2M (+25.6%), Intl $15.3M (+24.4%).
Net loss $6.5M improved $8.7M YoY; diluted EPS loss $0.14 vs $0.33.
Adjusted EBITDA positive $1.9M vs negative $4.2M in prior year.
FY 2023 revenue guidance $385-392M (17-19% growth); adj. EBITDA ~$2M; adj. EPS loss $1.10-$1.15.
Gross margin 74.5% flat YoY; operating loss $5.8M improved from $14.2M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.